Trial Profile
Efficacy and Safety of Rivaroxaban in Patients With Venous Thromboembolism and Active Malignancy - A Single Center Registry
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 15 Feb 2016 New trial record